Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trypanosoma cruzi | 33 | 2022 | 157 | 4.680 |
Why?
|
| Chagas Disease | 19 | 2022 | 104 | 2.940 |
Why?
|
| Protozoan Proteins | 10 | 2020 | 191 | 1.180 |
Why?
|
| Trypanocidal Agents | 6 | 2019 | 40 | 1.060 |
Why?
|
| Oxadiazoles | 3 | 2015 | 15 | 0.940 |
Why?
|
| Imidazoles | 5 | 2018 | 142 | 0.800 |
Why?
|
| Cytochrome P-450 Enzyme System | 6 | 2015 | 98 | 0.710 |
Why?
|
| Thrombospondin 1 | 4 | 2022 | 23 | 0.680 |
Why?
|
| alpha-Defensins | 2 | 2013 | 22 | 0.660 |
Why?
|
| Drug Discovery | 2 | 2019 | 108 | 0.580 |
Why?
|
| Antiprotozoal Agents | 3 | 2018 | 31 | 0.540 |
Why?
|
| RNA Interference | 3 | 2010 | 247 | 0.520 |
Why?
|
| Coronary Vessels | 2 | 2010 | 92 | 0.520 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2010 | 91 | 0.500 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 436 | 0.490 |
Why?
|
| Epithelial Cells | 3 | 2018 | 434 | 0.480 |
Why?
|
| Animals | 34 | 2022 | 16992 | 0.470 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2015 | 17 | 0.460 |
Why?
|
| Benzamides | 2 | 2015 | 81 | 0.450 |
Why?
|
| Cocaine | 4 | 2020 | 251 | 0.440 |
Why?
|
| Enzyme Inhibitors | 4 | 2013 | 458 | 0.430 |
Why?
|
| Flagella | 1 | 2013 | 32 | 0.400 |
Why?
|
| Laminin | 2 | 2006 | 58 | 0.400 |
Why?
|
| Host-Parasite Interactions | 3 | 2009 | 79 | 0.400 |
Why?
|
| Locomotion | 1 | 2013 | 105 | 0.380 |
Why?
|
| Defensins | 1 | 2010 | 5 | 0.340 |
Why?
|
| Receptors, Cell Surface | 2 | 2009 | 146 | 0.330 |
Why?
|
| Humans | 38 | 2025 | 43102 | 0.320 |
Why?
|
| Gene Regulatory Networks | 2 | 2016 | 149 | 0.320 |
Why?
|
| Trypanosoma brucei brucei | 4 | 2014 | 82 | 0.320 |
Why?
|
| Casein Kinase II | 2 | 2008 | 17 | 0.320 |
Why?
|
| Drug Design | 5 | 2018 | 186 | 0.310 |
Why?
|
| Mice | 16 | 2022 | 6644 | 0.310 |
Why?
|
| MicroRNAs | 3 | 2020 | 518 | 0.300 |
Why?
|
| Mice, Inbred BALB C | 5 | 2015 | 694 | 0.290 |
Why?
|
| Endothelial Cells | 3 | 2022 | 329 | 0.280 |
Why?
|
| HIV-1 | 5 | 2020 | 755 | 0.280 |
Why?
|
| Aspergillus fumigatus | 2 | 2018 | 13 | 0.280 |
Why?
|
| Biomedical Research | 2 | 2025 | 502 | 0.280 |
Why?
|
| Variant Surface Glycoproteins, Trypanosoma | 2 | 2014 | 8 | 0.270 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2019 | 166 | 0.270 |
Why?
|
| Ligands | 7 | 2021 | 388 | 0.260 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 98 | 0.260 |
Why?
|
| Galectin 3 | 2 | 2004 | 30 | 0.260 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 314 | 0.260 |
Why?
|
| Myoblasts, Cardiac | 1 | 2006 | 4 | 0.250 |
Why?
|
| Trypanosomiasis | 2 | 2007 | 2 | 0.250 |
Why?
|
| Cell Membrane | 4 | 2013 | 403 | 0.240 |
Why?
|
| Colonialism | 1 | 2025 | 4 | 0.240 |
Why?
|
| Antifungal Agents | 4 | 2018 | 169 | 0.240 |
Why?
|
| Antigens, Protozoan | 2 | 2006 | 74 | 0.230 |
Why?
|
| Gene Silencing | 1 | 2006 | 154 | 0.230 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2017 | 83 | 0.230 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2022 | 60 | 0.220 |
Why?
|
| Mucins | 2 | 2002 | 73 | 0.210 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 140 | 0.200 |
Why?
|
| 3' Untranslated Regions | 2 | 2020 | 82 | 0.190 |
Why?
|
| Membrane Proteins | 1 | 2006 | 561 | 0.190 |
Why?
|
| Pain | 1 | 2025 | 290 | 0.190 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 1596 | 0.180 |
Why?
|
| Naegleria fowleri | 1 | 2021 | 2 | 0.180 |
Why?
|
| Cell Fusion | 1 | 2001 | 19 | 0.180 |
Why?
|
| Neuraminidase | 3 | 2008 | 9 | 0.180 |
Why?
|
| Substrate Specificity | 6 | 2021 | 219 | 0.180 |
Why?
|
| Myocardium | 2 | 2020 | 263 | 0.180 |
Why?
|
| beta Catenin | 1 | 2022 | 78 | 0.170 |
Why?
|
| Rats | 5 | 2022 | 3735 | 0.170 |
Why?
|
| Proline | 1 | 2021 | 40 | 0.170 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2019 | 127 | 0.170 |
Why?
|
| Myoblasts | 1 | 2020 | 30 | 0.160 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2021 | 69 | 0.160 |
Why?
|
| Antigens, Differentiation | 1 | 2000 | 22 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2025 | 590 | 0.160 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2020 | 21 | 0.160 |
Why?
|
| Glutamic Acid | 1 | 2021 | 131 | 0.160 |
Why?
|
| Candida albicans | 2 | 2018 | 176 | 0.150 |
Why?
|
| Myocytes, Cardiac | 3 | 2020 | 183 | 0.150 |
Why?
|
| Capsid | 1 | 2020 | 65 | 0.150 |
Why?
|
| Nucleus Accumbens | 1 | 2020 | 100 | 0.150 |
Why?
|
| Homeostasis | 1 | 2021 | 192 | 0.150 |
Why?
|
| Molecular Structure | 4 | 2015 | 570 | 0.150 |
Why?
|
| Triazoles | 4 | 2017 | 102 | 0.150 |
Why?
|
| Extracellular Matrix | 1 | 2000 | 131 | 0.150 |
Why?
|
| Nitroimidazoles | 1 | 2019 | 11 | 0.150 |
Why?
|
| Sterols | 4 | 2012 | 24 | 0.150 |
Why?
|
| Dipeptidases | 1 | 2019 | 9 | 0.150 |
Why?
|
| Tetrazoles | 2 | 2017 | 46 | 0.150 |
Why?
|
| Microvessels | 1 | 2019 | 31 | 0.150 |
Why?
|
| Methamphetamine | 1 | 2021 | 166 | 0.150 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 306 | 0.150 |
Why?
|
| Virus Release | 2 | 2016 | 9 | 0.140 |
Why?
|
| Pyridines | 2 | 2017 | 139 | 0.140 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 1070 | 0.140 |
Why?
|
| Amino Acid Sequence | 3 | 2010 | 1180 | 0.140 |
Why?
|
| Artificial Intelligence | 1 | 2019 | 112 | 0.130 |
Why?
|
| Drugs, Investigational | 1 | 2017 | 1 | 0.130 |
Why?
|
| Colon | 1 | 2018 | 120 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2018 | 1621 | 0.130 |
Why?
|
| Protein Binding | 5 | 2017 | 1082 | 0.130 |
Why?
|
| Proteome | 1 | 2018 | 152 | 0.130 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 173 | 0.130 |
Why?
|
| Cell Adhesion | 3 | 2004 | 238 | 0.130 |
Why?
|
| Phosphoproteins | 1 | 2018 | 206 | 0.130 |
Why?
|
| Crystallography, X-Ray | 5 | 2018 | 280 | 0.130 |
Why?
|
| Protein Conformation | 5 | 2018 | 416 | 0.120 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2016 | 4 | 0.120 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2016 | 9 | 0.120 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2016 | 8 | 0.120 |
Why?
|
| Proline Oxidase | 1 | 2015 | 11 | 0.120 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 1542 | 0.120 |
Why?
|
| Antigens, CD | 1 | 2016 | 127 | 0.110 |
Why?
|
| Minority Groups | 1 | 2021 | 690 | 0.110 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2015 | 54 | 0.110 |
Why?
|
| Models, Molecular | 5 | 2018 | 876 | 0.110 |
Why?
|
| Biotransformation | 1 | 2015 | 69 | 0.110 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 99 | 0.110 |
Why?
|
| Ergosterol | 1 | 2014 | 12 | 0.110 |
Why?
|
| Microsomes, Liver | 1 | 2015 | 75 | 0.110 |
Why?
|
| Carbamates | 1 | 2014 | 13 | 0.110 |
Why?
|
| Binding Sites | 3 | 2020 | 671 | 0.110 |
Why?
|
| Tissue Distribution | 1 | 2015 | 240 | 0.110 |
Why?
|
| Adenoviridae | 1 | 2014 | 62 | 0.110 |
Why?
|
| Glycoproteins | 2 | 2008 | 125 | 0.110 |
Why?
|
| Autophagy | 1 | 2015 | 140 | 0.110 |
Why?
|
| Genetic Vectors | 1 | 2014 | 165 | 0.100 |
Why?
|
| Capsid Proteins | 1 | 2014 | 76 | 0.100 |
Why?
|
| HCT116 Cells | 1 | 2013 | 40 | 0.100 |
Why?
|
| Molecular Weight | 2 | 2006 | 168 | 0.100 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 506 | 0.100 |
Why?
|
| Cocaine-Related Disorders | 1 | 2014 | 102 | 0.100 |
Why?
|
| Macrophages | 3 | 2003 | 529 | 0.100 |
Why?
|
| HIV Infections | 2 | 2020 | 2586 | 0.100 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 2012 | 1 | 0.100 |
Why?
|
| Adaptor Protein Complex delta Subunits | 1 | 2012 | 1 | 0.100 |
Why?
|
| Calreticulin | 1 | 2012 | 8 | 0.090 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 19 | 0.090 |
Why?
|
| Monocytes | 2 | 2019 | 277 | 0.090 |
Why?
|
| Neurons | 2 | 2021 | 1263 | 0.090 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2012 | 16 | 0.090 |
Why?
|
| Virus Assembly | 1 | 2012 | 44 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2013 | 260 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2013 | 368 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 279 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2015 | 536 | 0.090 |
Why?
|
| Hela Cells | 2 | 2016 | 376 | 0.090 |
Why?
|
| Mutation | 4 | 2020 | 1177 | 0.080 |
Why?
|
| Signal Transduction | 4 | 2020 | 2157 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 704 | 0.080 |
Why?
|
| Apoptosis | 2 | 2017 | 1568 | 0.080 |
Why?
|
| Trypanosomiasis, African | 1 | 2009 | 22 | 0.080 |
Why?
|
| Immunoprecipitation | 2 | 2012 | 127 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2013 | 549 | 0.080 |
Why?
|
| Indomethacin | 1 | 2009 | 25 | 0.080 |
Why?
|
| Brain | 1 | 2017 | 1472 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 2 | 2002 | 306 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 310 | 0.070 |
Why?
|
| Trypanosoma | 1 | 2008 | 8 | 0.070 |
Why?
|
| Fibronectins | 1 | 1989 | 69 | 0.070 |
Why?
|
| Phagocytosis | 1 | 1989 | 86 | 0.070 |
Why?
|
| Amides | 1 | 2009 | 71 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2013 | 1604 | 0.070 |
Why?
|
| Nuclear Localization Signals | 1 | 2008 | 15 | 0.070 |
Why?
|
| Serine Endopeptidases | 1 | 2008 | 48 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 1 | 2008 | 64 | 0.070 |
Why?
|
| Response Elements | 1 | 2008 | 55 | 0.070 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 35 | 0.070 |
Why?
|
| Vacuoles | 1 | 2007 | 22 | 0.070 |
Why?
|
| Oxidoreductases | 1 | 2007 | 79 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 173 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 592 | 0.060 |
Why?
|
| Female | 4 | 2015 | 24698 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 160 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2010 | 181 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2007 | 154 | 0.060 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2008 | 92 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 2676 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2012 | 281 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2008 | 383 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2006 | 986 | 0.060 |
Why?
|
| Epidermal Growth Factor | 2 | 2003 | 70 | 0.060 |
Why?
|
| Virulence Factors | 1 | 2006 | 125 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 1869 | 0.060 |
Why?
|
| Microsomes | 2 | 2018 | 55 | 0.060 |
Why?
|
| Catalytic Domain | 2 | 2018 | 118 | 0.050 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2003 | 18 | 0.050 |
Why?
|
| Transfection | 1 | 2004 | 532 | 0.050 |
Why?
|
| Methyltransferases | 2 | 2014 | 68 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2017 | 245 | 0.050 |
Why?
|
| Hybridomas | 1 | 2002 | 24 | 0.050 |
Why?
|
| Immunoglobulin Fragments | 1 | 2002 | 12 | 0.050 |
Why?
|
| Endothelium | 1 | 2022 | 28 | 0.050 |
Why?
|
| Male | 5 | 2021 | 23409 | 0.040 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2001 | 13 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2008 | 1003 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 197 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2001 | 57 | 0.040 |
Why?
|
| Muscles | 1 | 2001 | 82 | 0.040 |
Why?
|
| Epitopes | 1 | 2002 | 157 | 0.040 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2021 | 17 | 0.040 |
Why?
|
| Maryland | 1 | 2021 | 66 | 0.040 |
Why?
|
| Cricetulus | 1 | 2021 | 82 | 0.040 |
Why?
|
| Cell Line | 1 | 2004 | 1410 | 0.040 |
Why?
|
| CHO Cells | 1 | 2021 | 123 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 155 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 60 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2021 | 47 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 458 | 0.040 |
Why?
|
| Lactose | 1 | 2000 | 16 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 53 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2000 | 52 | 0.040 |
Why?
|
| Heart | 1 | 2022 | 184 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2000 | 87 | 0.040 |
Why?
|
| Models, Animal | 1 | 2020 | 151 | 0.040 |
Why?
|
| Azoles | 2 | 2011 | 12 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 189 | 0.040 |
Why?
|
| Virus Integration | 1 | 2020 | 65 | 0.040 |
Why?
|
| Research Personnel | 1 | 2021 | 206 | 0.040 |
Why?
|
| Collagen | 1 | 2000 | 181 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2020 | 192 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1124 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 213 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2022 | 1035 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2019 | 128 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 456 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 234 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2019 | 195 | 0.040 |
Why?
|
| Drug Stability | 1 | 2018 | 129 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 241 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2000 | 883 | 0.030 |
Why?
|
| Annexin A5 | 1 | 2017 | 27 | 0.030 |
Why?
|
| Ketoconazole | 1 | 2017 | 8 | 0.030 |
Why?
|
| Endocytosis | 2 | 2012 | 118 | 0.030 |
Why?
|
| Fluconazole | 1 | 2017 | 41 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2017 | 59 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2017 | 92 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 561 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2017 | 136 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2017 | 462 | 0.030 |
Why?
|
| Cattle | 1 | 2017 | 498 | 0.030 |
Why?
|
| Proteomics | 1 | 2018 | 378 | 0.030 |
Why?
|
| Heme | 1 | 2015 | 72 | 0.030 |
Why?
|
| Fibrosis | 1 | 2016 | 169 | 0.030 |
Why?
|
| Itraconazole | 1 | 2014 | 13 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 712 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2014 | 169 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 457 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 749 | 0.030 |
Why?
|
| Virion | 1 | 2014 | 75 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 94 | 0.030 |
Why?
|
| Cholesterol | 1 | 2014 | 232 | 0.020 |
Why?
|
| Tropical Medicine | 1 | 2012 | 10 | 0.020 |
Why?
|
| Clathrin | 1 | 2012 | 21 | 0.020 |
Why?
|
| RNA | 1 | 2014 | 266 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 411 | 0.020 |
Why?
|
| Life Cycle Stages | 1 | 2012 | 29 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 532 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2012 | 107 | 0.020 |
Why?
|
| Metabolome | 1 | 2012 | 51 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 678 | 0.020 |
Why?
|
| Mitochondria | 1 | 2015 | 523 | 0.020 |
Why?
|
| Skin | 1 | 2012 | 187 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 667 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 518 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2009 | 30 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 182 | 0.020 |
Why?
|
| Neoplasms | 1 | 2021 | 1377 | 0.020 |
Why?
|
| Receptors, Fibronectin | 1 | 1989 | 3 | 0.020 |
Why?
|
| Antiparasitic Agents | 1 | 2009 | 11 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2009 | 36 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2009 | 37 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1989 | 114 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2012 | 460 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1989 | 73 | 0.020 |
Why?
|
| alpha Karyopherins | 1 | 2008 | 3 | 0.020 |
Why?
|
| beta Karyopherins | 1 | 2008 | 4 | 0.020 |
Why?
|
| Hydroquinones | 1 | 2008 | 10 | 0.020 |
Why?
|
| K562 Cells | 1 | 2008 | 32 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 97 | 0.020 |
Why?
|
| Peptides | 1 | 2008 | 372 | 0.010 |
Why?
|
| Tyrosine | 1 | 2003 | 120 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 311 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2002 | 100 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 592 | 0.010 |
Why?
|